Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $25.1M
Liabilities Breakdown FY2016
Total Liabilities: $35.2M
Asset Breakdown
Total Assets: $25.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $602.0K | 2.4% |
| Accounts Receivable | $2.2M | 8.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $929.0K | 3.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $36.4M | 144.6% |
Liabilities Breakdown
Total Liabilities: $35.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.3M | 6.6% |
| Long-Term Debt | $7.9M | 22.4% |
| Other Liabilities | $25.0M | 71.0% |